Inventor · disambiguated record
Tongqing Zhou
Also filed as: ZHOU TONGQING
28 granted patents·17 pending applications·123 citations·filing 2006–2025
96Inventor score
Files withUS HEALTH23THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC3UNIV DUKE3INT AIDS VACCINE INITIATIVE2KWONG PETER2
Top patents by PatentIndex Score
45 records- 0194US10035844B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2017·Granted Jul 31, 2018·6 cites·32 claims
- 0294US10017543B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2014·Granted Jul 10, 2018·26 cites·58 claims
- 0394US9738689B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2014·Granted Aug 22, 2017·19 cites·42 claims
- 0493US10400015B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2015·Granted Sep 3, 2019·10 cites·51 claims
- 0593US8637036B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2012·Granted Jan 28, 2014·22 cites·23 claims
- 0691US9695230B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2012·Granted Jul 4, 2017·9 cites·41 claims
- 0790US12202886B2Neutralizing antibodies to GP120 and their useUS HEALTH·Filed 2022·Granted Jan 21, 2025·1 cites·11 claims
- 0890US11459360B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2019·Granted Oct 4, 2022·4 cites·30 claims
- 0990US10562960B2Neutralizing antibodies to gp120 and their useUS HEALTH·Filed 2016·Granted Feb 18, 2020·5 cites·41 claims
- 1089US2025368690A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 1188US12435113B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2023·Granted Oct 7, 2025·0 cites·27 claims
- 1287US11981707B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2023·Granted May 14, 2024·0 cites·25 claims
- 1387US11130785B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2018·Granted Sep 28, 2021·2 cites·24 claims
- 1486US2025215068A1Neutralizing antibodies to gp120 and their useUS HEALTH·Filed 2024·Application pending·0 cites
- 1585US9738703B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2015·Granted Aug 22, 2017·2 cites·21 claims
- 1684US11602559B2HIV-1 Env fusion peptide immunogens and their useUS HEALTH·Filed 2017·Granted Mar 14, 2023·2 cites·16 claims
- 1784US10004800B2Antibody evolution immunogensUNIV DUKE·Filed 2013·Granted Jun 26, 2018·6 cites·24 claims
- 1884US9175070B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2010·Granted Nov 3, 2015·4 cites·7 claims
- 1981US11078239B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2017·Granted Aug 3, 2021·1 cites·24 claims
- 2080US12145968B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2022·Granted Nov 19, 2024·0 cites·13 claims
- 2180US10035845B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2017·Granted Jul 31, 2018·2 cites·21 claims
- 2278US12458691B2HIV-1 ENV fusion peptide immunogens and their useUS HEALTH·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 2376US8268323B2Conformationally stabilized HIV envelope immunogensKWONG PETER·Filed 2011·Granted Sep 18, 2012·2 cites·20 claims
- 2475US2022002351A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2021·Application pending·0 cites
- 2572US2021324053A1Neutralizing antibodies to gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2021·Application pending·0 cites
- 2666US10849970B2Antibody evolution immunogensUNIV DUKE·Filed 2018·Granted Dec 1, 2020·0 cites·30 claims
- 2766US2020231658A1Neutralizing antibodies to gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 2865US10815295B2Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2018·Granted Oct 27, 2020·0 cites·6 claims
- 2965US8044185B2Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopesUS HEALTH·Filed 2006·Granted Oct 25, 2011·0 cites·24 claims
- 3063US2025197455A1Base-covered hiv-1 envelope ectodomains and their useTTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVI·Filed 2023·Application pending·0 cites
- 3161US2012034254A1Antigenic cloaking and its useKWONG PETER D·Filed 2009·Application pending·0 cites
- 3260US9382311B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Jul 5, 2016·0 cites·8 claims
- 3360US2024109955A1Anti-sars-cov-2 antigen binding polypeptides, polypeptide complexes and methods of use thereofMODEX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3459US10858400B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2017·Granted Dec 8, 2020·0 cites·19 claims
- 3559US9796774B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Oct 24, 2017·0 cites·5 claims
- 3657US8715686B2Conformationally stabilized HIV envelope immunogensKWONG PETER·Filed 2012·Granted May 6, 2014·0 cites·20 claims
- 3757US2024299510A1Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteinsUS HEALTH·Filed 2021·Application pending·0 cites
- 3857US2019054182A1Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infectionSANOFI SA·Filed 2016·Application pending·0 cites
- 3956US2025188154A1Coronavirus antibodies and uses thereofUNIV DUKE·Filed 2021·Application pending·0 cites
- 4055US2024117011A1Antibodies targeting the spike protein of coronavirusesUS HEALTH·Filed 2022·Application pending·0 cites
- 4152US2023174587A1Recombinant human metapneumovirus f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2021·Application pending·0 cites
- 4247US2025326823A1Antigen Binding Polypeptides, Polypeptide Complexes and Methods of Use ThereofMODEX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4345US2010068217A1Epitope-transplant scaffolds and their useKWONG PETER D·Filed 2007·Application pending·0 cites
- 4442US2015044137A1Neutralizing antibodies to hiv-1 and their useUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEP OF HEALTH CARE HUMAN SERVICES·Filed 2013·Application pending·0 cites
- 4542US2014348865A1Immunogens based on an hiv-1 v1v2 site-of-vulnerabilityUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SER·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tongqing Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →